5

Table of Content Table of Content i Executive Summary 1 Introduction and policy context Background and Objectives 1.1 1.2 1.3 2.1 Definition of Blue Biotechnology sector 1.2.1 Definition of marine biotechnology 1.2.2 Defining the Blue Biotechnology sector Policy context 2 State of play: Importance of Blue Biotechnology Value chain of Blue Biotechnology 2.1.1 Discovery, bioprospecting and R&D- the blue components of the value chain 2.2 Overall size and structure of the Blue Biotechnology sector Size 2.2.1 2.2.2 2.5 3.1 Structure 2.3 Global settings of Blue Biotechnology 2.4 3 EU-level problem analysis Sector review 3.1.1 Overview of sub-sectors 3.1.2 Potential product areas in research and development 3.1.3 Landscape of Blue Biotechnology infrastructures 3.1.4 Socio-economic performance 3.1.5 The role of SMEs 3.1.6 Products and services already in use 3.1.7 3.1.8 Stakeholder Workshop 3.2 Network, cluster and policy analysis 3.2.1 FP6, FP7 and Horizon 2020 3.3 3.4 3.5 3.2.2 National, regional and European clusters, initiatives and networks 3.2.3 National policies in Europe Review of patent profiling 3.3.1 Positioning of Blue Biotechnology sector vis-à-vis other sectors 3.3.2 Global perspectives Regulatory Review 3.4.1 Intellectual Property Rights 3.4.2 Access and benefit sharing Conclusions 4 Objectives and policy options 4.1 Revisiting the barriers and problems Study in support of Impact Assessment work on Blue Biotechnology Drivers and barriers in the Blue Biotechnology sector Blue Biotechnology within the wider biotechnology landscape Conclusions i 1 1 1 1 2 3 5 5 6 2.1.2 Closing the marine biotechnology loop: the ‘blue’ application of marine biotechnology' 7 7 7 8 9 10 10 13 13 13 14 14 16 24 27 31 38 41 41 44 46 48 48 50 51 51 52 53 57 57

6 Publizr Home